Research & Literature

Phenotypic Variation in Different Lesions of Mycosis Fungoides Biopsied Within a Short Period of Time From the Same Patient.

Kash N, Massone C, Fink-Puches R, Cerroni L

The American Journal of dermatopathology 2016; (38(7)):541-5 doi:10.1097/DAD.0000000000000493.

Relative Frequency, Clinical Features, and Survival Outcomes of 395 Patients with Cutaneous Lymphoma in Korea: A Subgroup Analysis per 10-year Period.

Lee WJ, Lee SH, Moon IJ, et al.

Acta dermato-venereologica 2016; (96(7)):888-893 doi:10.2340/00015555-2404.

Diagnosing Spindle Cell Variant of Primary Cutaneous B-Cell Lymphoma: Potential Pitfalls and Solutions.

Forcucci J, Ralston J, Lazarchick J

Annals of clinical and laboratory science 2016; (46(2)):209-12.

Clinicopathological and molecular study of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma.

Alberti-Violetti S, Torres-Cabala CA, Talpur R, et al.

Journal of cutaneous pathology 2016; (43(12)):1121-1130 doi:10.1111/cup.12806.

Investigating potential exogenous tumor initiating and promoting factors for Cutaneous T-Cell Lymphomas (CTCL), a rare skin malignancy.

Litvinov IV, Shtreis A, Kobayashi K, et al.

Oncoimmunology 2016; (5(7)):e1175799 doi:10.1080/2162402X.2016.1175799.

Interleukin-12 immunohistochemistry as a diagnostic tool for patch-stage mycosis fungoides.

Lemchak DM, Akilov OE

Journal of the American Academy of Dermatology 2016; (75(5)):1053-1054 doi:10.1016/j.jaad.2016.06.019.

Staphylococcus aureus Induces Increased Serine Protease Activity in Keratinocytes.

Williams MR, Nakatsuji T, Sanford JA, et al.

The Journal of investigative dermatology 2017; (137(2)):377-384 doi:10.1016/j.jid.2016.10.008.

Staphylococcus aureus colonization in atopic eczema and its association with filaggrin gene mutations.

Clausen ML, Edslev SM, Andersen PS, et al.

The British journal of dermatology 2017; (177(5)):1394-1400 doi:10.1111/bjd.15470.

Management Strategies for Mycosis Fungoides in India.

Raychaudhury T

Indian journal of dermatology 2017; (62(2)):137-141 doi:10.4103/ijd.IJD_71_17.

CD4+CD26- lymphocytes are useful to assess blood involvement and define B ratings in cutaneous T cell lymphoma.

Vonderheid EC, Hou JS

Leukemia & lymphoma 2018; (59(2)):330-339 doi:10.1080/10428194.2017.1334123.

Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoproliferative disorder: Report of a case and review of the literature.

Keeling BH, Gavino ACP, Admirand J, Soldano AC

Journal of cutaneous pathology 2017; (44(11)):944-947 doi:10.1111/cup.13011.

Monoclonal antibodies against cutaneous T-cell lymphomas.

Alaibac M

Expert opinion on biological therapy 2017; (17(12)):1503-1510 doi:10.1080/14712598.2017.1369951.

Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, With Spontaneous Regression After Biopsy.

Marrero-Alemán G, Montenegro-Dámaso T, Peñate Y

The American Journal of dermatopathology 2017; (39(10)):785-787 doi:10.1097/DAD.0000000000000874.

Use of oral antidepressants in patients with chronic pruritus: A systematic review.

Kouwenhoven TA, van de Kerkhof PCM, Kamsteeg M

Journal of the American Academy of Dermatology 2017; (77(6)):1068-1073.e7 doi:10.1016/j.jaad.2017.08.025.

Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force.

Scarisbrick JJ, Hodak E, Bagot M, et al.

European journal of cancer (Oxford, England : 1990) 2018; (93()):47-56 doi:10.1016/j.ejca.2018.01.076.

[Primary cutaneous lymphoma-a case series of 163 patients].

Nashan D, Friedrich CM, Geissler E, et al.

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 2018; (69(12)):1014-1020 doi:10.1007/s00105-018-4212-8.

Pruritus in Cutaneous T-Cell Lymphoma and Its Management.

Serrano L, Martinez-Escala ME, Zhou XA, Guitart J

Dermatologic clinics 2018; (36(3)):245-258 doi:10.1016/j.det.2018.02.011.

Clinical and epidemiological profile of patients with early stage mycosis fungoides.

Amorim GM, Niemeyer-Corbellini JP, Quintella DC, et al.

Anais brasileiros de dermatologia 2018; (93(4)):546-552 doi:10.1590/abd1806-4841.20187106.

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.

Kim YH, Bagot M, Pinter-Brown L, et al.

The Lancet. Oncology 2018; (19(9)):1192-1204 doi:10.1016/S1470-2045(18)30379-6.

The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients.

Scarisbrick JJ, Quaglino P, Prince HM, et al.

The British journal of dermatology 2019; (181(2)):350-357 doi:10.1111/bjd.17258.

Primary cutaneous lymphoma in Argentina: a report of a nationwide study of 416 patients.

Abeldaño A, Enz P, Maskin M, et al.

International journal of dermatology 2019; (58(4)):449-455 doi:10.1111/ijd.14262.

Comparison of Narrowband UV-B With Psoralen-UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides: A Systematic Review and Meta-analysis.

Phan K, Ramachandran V, Fassihi H, Sebaratnam DF

JAMA dermatology 2019; (155(3)):335-341 doi:10.1001/jamadermatol.2018.5204.

Health-related quality of life and economic implications of cutaneous T-cell lymphoma.

Semenov YR, Rosenberg AR, Herbosa C, et al.

The British journal of dermatology 2020; (182(1)):190-196 doi:10.1111/bjd.17941.

Skin Directed Therapy in Cutaneous T-Cell Lymphoma.

Tarabadkar ES, Shinohara MM

Frontiers in oncology 2019; (9()):260 doi:10.3389/fonc.2019.00260.

Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study.

Molloy K, Jonak C, Woei-A-Jin FJSH, et al.

The British journal of dermatology 2020; (182(3)):770-779 doi:10.1111/bjd.18089.

Effectiveness of lenalidomide in relapsed primary cutaneous diffuse large B-cell lymphoma, leg type.

Al Dhafiri M, Sicre de Fontbrune F, Marinho E, et al.

Clinical case reports 2019; (7(5)):964-967 doi:10.1002/ccr3.2137.

Clinical characteristics of primary cutaneous lymphoma: analysis from two centres in China.

Shi HZ, Liu YX, Jiang YQ, et al.

The British journal of dermatology 2019; (181(6)):1332-1333 doi:10.1111/bjd.18266.

Evaluation of haematopoietic stem cell transplantation in patients diagnosed with cutaneous T-cell lymphoma at a tertiary care centre: should we avoid chemotherapy in conditioning regimes?

Ritchie S, Qureshi I, Molloy K, et al.

The British journal of dermatology 2020; (182(3)):807-809 doi:10.1111/bjd.18541.

Leukaemic variants of cutaneous T-cell lymphoma: Erythrodermic mycosis fungoides and Sézary syndrome.

Martinez XU, Di Raimondo C, Abdulla FR, et al.

Best practice & research. Clinical haematology 2019; (32(3)):239-252 doi:10.1016/j.beha.2019.06.004.

A case of a primary cutaneous diffuse large B-cell lymphoma, leg type.

Marasca C, Fabbrocini G, Cinelli E, et al.

International wound journal 2020; (17(2)):514-515 doi:10.1111/iwj.13298.

Pruritic Manifestation of Peripheral T Cell Lymphoma Effectively Managed with Mirtazapine: A Case Report.

Bromberg H, Chang Y, Craig D

Journal of pain & palliative care pharmacotherapy 2020; (34(3)):153-154 doi:10.1080/15360288.2020.1734142.

18FDG PET/CT in Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type.

Dejust S, Morland D, Durot E, et al.

Clinical nuclear medicine 2020; (45(5)):403-404 doi:10.1097/RLU.0000000000002995.

Current measures are not sufficient: an interview-based qualitative assessment of quality of life in cutaneous T-cell lymphoma.

Bhat TS, Herbosa CM, Rosenberg AR, et al.

The British journal of dermatology 2021; (184(2)):310-318 doi:10.1111/bjd.19298.

Sézary syndrome and mycosis fungoides: An overview, including the role of immunophenotyping.

Pulitzer MP, Horna P, Almeida J

Cytometry. Part B, Clinical cytometry 2021; (100(2)):132-138 doi:10.1002/cyto.b.21888.

Primary Cutaneous B-Cell Lymphomas: An Update.

Vitiello P, Sica A, Ronchi A, et al.

Frontiers in oncology 2020; (10()):651 doi:10.3389/fonc.2020.00651.

Systemic chemotherapy promotes HIF-1α-mediated glycolysis and IL-17F pathways in cutaneous T-cell lymphoma.

Wang B, Li K, Wang H, et al.

Experimental dermatology 2020; (29(10)):987-992 doi:10.1111/exd.14133.

Long-standing dermatitis treated with dupilumab with subsequent progression to cutaneous T-cell lymphoma.

Hollins LC, Wirth P, Fulchiero GJ, Foulke GT

Cutis 2020; (106(2)):E8-E11 doi:10.12788/cutis.0074.

A nose for trouble: Marginal zone lymphoma masquerading as cutaneous lupus erythematosus.

Mangkorntongsakul V, Charlton OA, Phan K, et al.

Dermatologic therapy 2020; (33(6)):e14409 doi:10.1111/dth.14409.

Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry.

Dobos G, de Masson A, Ram-Wolff C, et al.

The British journal of dermatology 2021; (184(6)):1059-1067 doi:10.1111/bjd.19644.

Prospective observational trial of low-dose skin electron beam therapy in mycosis fungoides using a rotational technique.

Newman NB, Patel CG, Ding GX, et al.

Journal of the American Academy of Dermatology 2021; (85(1)):121-127 doi:10.1016/j.jaad.2020.12.023.

The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Current and future approaches.

Weiner DM, Durgin JS, Wysocka M, Rook AH

Journal of the American Academy of Dermatology 2021; (84(3)):597-604 doi:10.1016/j.jaad.2020.12.026.

Cutaneous T-cell lymphoma mimicking palmoplantar pustular psoriasis: A rare variant.

Hignett E, Seminario-Vidal L, Shulman K, Sami N

The Australasian journal of dermatology 2021; (62(2)):e280-e282 doi:10.1111/ajd.13544.

Colonization With Staphylococcus aureus in Atopic Dermatitis Patients: Attempts to Reveal the Unknown.

Ogonowska P, Gilaberte Y, Barańska-Rybak W, Nakonieczna J

Frontiers in microbiology 2020; (11()):567090 doi:10.3389/fmicb.2020.567090.

Acceleration of cutaneous T-cell lymphoma following dupilumab administration.

Russomanno K, Carver DeKlotz CM

JAAD case reports 2021; (8()):83-85 doi:10.1016/j.jdcr.2020.12.010.

Phototherapy as a treatment of early-stage mycosis fungoides and predictive factors for disease recurrence: A 17-year retrospective study.

Rattanakaemakorn P, Ploydaeng M, Udompanich S, et al.

Indian journal of dermatology, venereology and leprology 2021; (87(5)):645-650.

Mycosis fungoides and Sézary syndrome: focus on the current treatment scenario.

Sanches JA, Cury-Martins J, Abreu RM, et al.

Anais brasileiros de dermatologia 2021; (96(4)):458-471 doi:10.1016/j.abd.2020.12.007.

Evolution of Dupilumab-Associated Cutaneous Atypical Lymphoid Infiltrates.

Sokumbi O, Shamim H, Davis MDP, et al.

The American Journal of dermatopathology 2021; (43(10)):714-720 doi:10.1097/DAD.0000000000001875.

Cutaneous T cell lymphoma.

Dummer R, Vermeer MH, Scarisbrick JJ, et al.

Nature reviews. Disease primers 2021; (7(1)):61 doi:10.1038/s41572-021-00296-9.

Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data.

Horwitz SM, Scarisbrick JJ, Dummer R, et al.

Blood advances 2021; (5(23)):5098-5106 doi:10.1182/bloodadvances.2021004710.

A clinician's guide to cutaneous T-cell lymphoma presenting as recalcitrant eczematous dermatitis in adults.

Semaan S, Abel MK, Raffi J, Murase JE

International journal of women's dermatology 2021; (7(4)):422-427 doi:10.1016/j.ijwd.2021.04.004.

Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC.

Olsen EA, Whittaker S, Willemze R, et al.

Blood 2022; (140(5)):419-437 doi:10.1182/blood.2021012057.

Pathogenesis of cutaneous T cell lymphoma: Involvement of Staphylococcus aureus.

Fujii K

The Journal of dermatology 2022; (49(2)):202-209 doi:10.1111/1346-8138.16288.

Safety and Danger Considerations of Novel Treatments for Atopic Dermatitis in Context of Primary Cutaneous Lymphomas.

Kołkowski K, Trzeciak M, Sokołowska-Wojdyło M

International journal of molecular sciences 2021; (22(24)) doi:10.3390/ijms222413388.

Recurrent Bacterial Infections in Cutaneous T-cell Lymphoma.

Adithya Sateesh B, Bhagat YV, Thomas SE, et al.

Cureus 2022; (14(1)):e20912 doi:10.7759/cureus.20912.

"Knock Me Out": The Challenges of Managing Pain Due to Cutaneous T Cell Lymphomas: A Case Report.

Pandey S, Dolan A, Norton-Westbrook M, Desai AV

Journal of palliative medicine 2022; (25(11)):1740-1746 doi:10.1089/jpm.2021.0561.

The Treatment of Advanced-Stage Mycosis Fungoides and Sezary Syndrome: a Hematologist's Point of View.

Giordano A, Pagano L

Mediterranean journal of hematology and infectious diseases 2022; (14(1)):e2022029 doi:10.4084/MJHID.2022.029.

Chlormethine gel is effective for the treatment of skin lesions in patients with early- and late-stage mycosis fungoides in clinical practice.

Papadavid E, Koumourtzis M, Nikolaou V, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2022; (36(10)):1751-1757 doi:10.1111/jdv.18183.

Chlormethine Gel for the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma: In Vitro Release and Permeation Testing.

Giuliano C, Frizzarin S, Alonzi A, et al.

Dermatology and therapy 2022; (12(11)):2517-2529 doi:10.1007/s13555-022-00813-y.

Mycosis fungoides and Sézary syndrome: clinical presentation, diagnosis, staging, and therapeutic management.

Miyashiro D, Sanches JA

Frontiers in oncology 2023; (13()):1141108 doi:10.3389/fonc.2023.1141108.

Cutaneous B-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management.

Hristov AC, Tejasvi T, Wilcox RA

American journal of hematology 2023; (98(8)):1326-1332 doi:10.1002/ajh.26968.

What's New in Cutaneous T-Cell Lymphoma-Associated Pruritus.

Biazus Soares G, Guitart J, Yosipovitch G

American journal of clinical dermatology 2024; (25(1)):67-77 doi:10.1007/s40257-023-00823-2.

An unusual case of B-cell lymphoma of the scalp.

Chaudhry N, Qureshi A, Gollamudi S, et al.

Journal of surgical case reports 2023; (2023(11)):rjad639 doi:10.1093/jscr/rjad639.

Unveiling the hidden struggles: Exploring the profound impact of advanced stage cutaneous T-cell lymphoma on quality of life.

Ottevanger R, Feenstra JS, van Vliet LM, et al.

Skin health and disease 2023; (3(6)):e300 doi:10.1002/ski2.300.

Health-related quality of life and its influencing factors in patients with primary cutaneous B-cell lymphomas: A multicentric study in 100 patients.

Schirren AEC, Albrecht JD, Melchers S, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2024; (38(5)):954-966 doi:10.1111/jdv.19799.

Cutaneous T-Cell Lymphoma and Microbiota: Etiopathogenesis and Potential New Therapeutic Targets.

Rodríguez Baeza D, Bejarano Antonio L, González de Arriba M, et al.

Dermatology research and practice 2024; (2024()):9919225 doi:10.1155/2024/9919225.

Additional Findings of 18 F-AIF-FAPI-42 PET/CT in a Patient With Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma : Comparisons With 18 F-FDG PET/CT.

Liu G, Li Y, Du B, et al.

Clinical nuclear medicine 2024; (49(5)):e199-e201 doi:10.1097/RLU.0000000000005132.

Device-based physical therapies in chronic pruritus: A narrative review.

Zhu J, Zhao X, Navarini AA, Mueller SM

Journal of the American Academy of Dermatology 2024; (91(4)):699-705 doi:10.1016/j.jaad.2024.06.045.

Coexistence of large cell transformed mycosis fungoides and diffuse large B-cell lymphoma in one patient.

Rohan TZ, Suriano J, Tekmen V, et al.

Journal of cutaneous pathology 2024; (51(10)):761-766 doi:10.1111/cup.14673.

The skin microbiome stratifies patients with cutaneous T cell lymphoma and determines event-free survival.

Licht P, Dominelli N, Kleemann J, et al.

NPJ biofilms and microbiomes 2024; (10(1)):74 doi:10.1038/s41522-024-00542-4.

Radiation therapy for a case of poikilodermatous plaques in an otherwise healthy young man: A case report.

Biba U, Poppens MJ, Collier EK, Cheng K

SAGE open medical case reports 2024; (12()):2050313X241274837 doi:10.1177/2050313X241274837.

Nanopore Sequencing for T-Cell Receptor Rearrangement Analysis in Cutaneous T-Cell Lymphoma.

Cieslak C, Hain C, Rückert-Reed C, et al.

Cancers 2024; (16(21)) doi:10.3390/cancers16213700.

Integrative epidemiology and immunotranscriptomics uncover a risk and potential mechanism for cutaneous lymphoma unmasking or progression with dupilumab therapy.

Cabrera-Perez JS, Carey VJ, Odejide OO, et al.

The Journal of allergy and clinical immunology 2025; (155(5)):1584-1594 doi:10.1016/j.jaci.2024.10.028.

Chlormethine Gel for Treatment of Patients with Mycosis Fungoides: Best Practices and Guidance to Clinicians.

Geskin L, Querfeld C, Hodak E, et al.

Dermatology and therapy 2025; (15(1)):61-73 doi:10.1007/s13555-024-01305-x.

Tumors in the setting of dupilumab use: A review of the literature.

Guo S, Wang L, Bu D, Liu F

The World Allergy Organization journal 2025; (18(1)):101006 doi:10.1016/j.waojou.2024.101006.

Haematopoietic stem cell transplant in cutaneous T-cell lymphomas: A multicentre propensity-score matched study.

Bejarano L, Grau-Pérez M, Paíno-Román M, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2026; (40(1)):99-108 doi:10.1111/jdv.20638.

Total skin electron beam therapy.

Specht L

Frontiers in oncology 2025; (15()):1498855 doi:10.3389/fonc.2025.1498855.

Fatal mycosis fungoides, misdiagnosed as contact dermatitis.

Shadmani G, Dumrongkulraksa J, Jahromi AH

EJNMMI reports 2025; (9(1)):15 doi:10.1186/s41824-025-00249-5.

Concomitant Squamous Cell Carcinoma and Mycosis Fungoides Within the Same Lesion: A Case Report and Literature Review.

Mehta A, Bowling A, Gordon ER, et al.

The American Journal of dermatopathology 2025; (47(6)):472-476 doi:10.1097/DAD.0000000000002975.

Mycosis fungoides: a review.

Sheern C, Levell NJ, Craig PJ, et al.

Clinical and experimental dermatology 2025; (50(12)):2365-2375 doi:10.1093/ced/llaf341.

Skin-Directed Therapies in Mycosis Fungoides: An Update.

Tota M, Łyko M, Misiąg P, et al.

Dermatology and therapy 2025; (15(10)):2765-2801 doi:10.1007/s13555-025-01511-1.

The Overlapping Clinicopathological Presentations of Pityriasis Lichenoides and Mycosis Fungoides.

Pierog O, Estill M, Jedrych J, et al.

Journal of cutaneous pathology 2025; (52(12)):785-794 doi:10.1111/cup.14856.

Allogeneic haematopoietic cell transplant in cutaneous T-cell lymphomas: Recommendations from the EBMT PH&G Committee.

Damaj G, de Masson A, Dreger P, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2025; doi:10.1111/jdv.70042.

Exploring online discussions for those living with cutaneous T cell lymphoma: a qualitative study.

Park JJS, Shinohara M

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2025; (33(11)):953 doi:10.1007/s00520-025-09945-1.

[Primary cutaneous B-cell lymphomas-an overview of established and novel aspects].

Hansen-Abeck I, Menz A, Schneider SW, Booken N

Dermatologie (Heidelberg, Germany) 2025; (76(11)):735-748 doi:10.1007/s00105-025-05605-x.

Dupilumab therapy in atopic dermatitis when cutaneous lymphoma is suspected: Consensus recommendations from the EORTC Cutaneous Lymphoma Tumour Group.

Calvão J, de Masson A, Cozzio A, et al.

The Journal of allergy and clinical immunology 2026; (157(6)):1237-1245 doi:10.1016/j.jaci.2026.04.002.